Medically reviewed by: Dr Hoe Ying Min, Medical Director, Bay Aesthetics Clinic Last medically reviewed: July 2026 Semaglutide is a GLP-1 receptor agonist medication used to treat type 2 diabetes and, in higher doses, obesity
In contrast, Tirzepatide has been found to cause gastrointestinal side effects like vomiting along with an increased risk of hypoglycemia (low blood sugar)
Its flavorful and easy to portion out depending on your appetite, making it a good family-friendly meal that can be enjoyed by those who take GLP-1 meds, as well as those who dont
Since starting GOLO I have lost 110 lbs
4 Department of Gastroenterology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, Peoples Republic of China